Bojana Vulevic

584 citations
7 papers · 424 indexed · h-index 7
Topics
Drug Transport and Resistance Mechanisms (3 papers)Microtubule and mitosis dynamics (3 papers)Cholesterol and Lipid Metabolism (2 papers)
Partner nations
United States

In The Last Decade

Bojana Vulevic

7 papers receiving 418 citations

Peers

Bojana Vulevic
Comparison fields: 5 of 79
  • Oncology 236
  • Molecular Biology 222
  • Cell Biology 96
  • Surgery 84
  • Organic Chemistry 39
Replace Gerd Nagel with:
Gerd Nagel Germany
Susan H. Sorrell United States
Takashi Tsuruo Japan
Mário Šereš Slovakia
Andrea L. Merz United States
Makoto Hamada Japan
Maureen Bourner United States
Robert Mintzer United States
F. H. Hausheer United States
Jianxin Yu China
Bojana Vulevic relative to Gerd Nagel Germany Gerd Nagel's profile →
Citations per field
00.5×
Gerd Nagel · 1×
Citations per year

Countries citing papers authored by Bojana Vulevic

Since Specialization
Citations

This map shows the geographic impact of Bojana Vulevic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bojana Vulevic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bojana Vulevic more than expected).

Fields of papers citing papers by Bojana Vulevic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bojana Vulevic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bojana Vulevic. The network helps show where Bojana Vulevic may publish in the future.

Co-authorship network of co-authors of Bojana Vulevic

This figure shows the co-authorship network connecting the top 25 collaborators of Bojana Vulevic. A scholar is included among the top collaborators of Bojana Vulevic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bojana Vulevic. Bojana Vulevic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 6
2 57
3
Cloning and characterization of human adenosine 5'-triphosphate-binding cassette, sub-family A, transporter 2 (ABCA2).
73
4 47
5 56
6 6
7 179

About Bojana Vulevic

Bojana Vulevic is a scholar working on Cell Biology, Oncology and Biochemistry, having authored 7 papers that have together received 424 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (3 papers), Microtubule and mitosis dynamics (3 papers) and Cholesterol and Lipid Metabolism (2 papers). The work is most often cited by research in Oncology (236 citations), Cell Biology (96 citations) and Pharmacology (30 citations). Bojana Vulevic has collaborated with scholars based in United States. Frequent co-authors include Sharon Lobert, John J. Correia, John J. Correia, Kenneth D. Tew, Jonathan T. Boyd, Warren Davis, Martin G. Belinsky, Zhe Chen, Eric S. Walsh and Stephan T. Freer. Their work appears in journals such as Biochemistry, The FASEB Journal and Biophysical Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026